Board of Directors

Mr. Lewin has served on our Board since September 2015, and as Chairman since December 2017. He has been a Managing Partner at Crown Predator Holdings and a private investor since 2000. He has invested across multiple industries, with a particular focus on companies with innovative technologies and strong intellectual property, including activist situations that require working with management. He has been a director of Halo Maritime Defense Systems, a privately held provider of maritime security products and solutions, since 2007. Mr. Lewin also served as a director of Dura Medic, LLC a durable medical equipment provider from 2006 to 2018. He holds a bachelor’s degree in Political Science from Johns Hopkins University. 

Mr. Chacón-Quirós founded Establishment Labs (NASDAQ : ESTA) in 2004 and serves as the Chief Executive Officer and a Board Director. Mr. Chacón Quirós has been involved in several sectors of the aesthetics industry, including serving for a decade as General Manager of an aesthetic medical device distribution business in Latin America and prior to that as Business Development Manager of a renowned plastic and reconstructive surgery clinic in Costa Rica. He has co-authored more than 50 patents that are helping advance Medtech in areas like implantable devices and biocompatible surfaces, RFID and biosensors, 3D technology and the development of minimally invasive surgical instruments. He served as President of the Rugby Federation of Costa Rica from 2009 to 2015. Mr. Chacón-Quirós received his Baccalaureate from the Academie de Poitiers (Economics) and attended the University of Massachusetts at Amherst. He holds the MIT Sloan Advanced Certificate for Executives (ACE) in Management, Innovation and Technology.

Ms. Colleran has served on our Board since November 2015. She served as Global President of LifeCell Corporation from August 2008 to January 2012 after the company was acquired by Kinetic Concepts, Inc. In January 2012, Ms. Colleran was appointed Chief Executive Officer and Director of LifeCell Corporation, a position she held until April 2013. Ms. Colleran originally joined LifeCell in 2002 as the Vice President of Marketing and Business Development and later served as Senior Vice President of Commercial Operations. Before joining LifeCell, Ms. Colleran spent 20 years at Baxter Healthcare Corporation in various sales, marketing, business development, and general management roles with international experience. She was appointed Vice President, Marketing for Baxter's U.S. Renal business in 1997 and served in that role until 2001 when she was promoted to Vice President/General Manager of the company's Renal Pharmaceuticals business. Ms. Colleran has served on the Board of Directors of Tela Bio, Inc. since April 2020, and she previously served on the Board of Rockwell Medical, Inc. from March 2018 to April 2020, NOVADAQ Technologies Inc. from January 2017 to August 2017 and AxoGen Corporation from July 2018 to October 2018. Ms. Colleran received her Bachelor of Science from Molloy College and an M.B.A. from the Loyola University of Chicago.

Mr. Condon has served on our Board since December 2017. He was President and Chief Executive Officer of Merz Aesthetics (formerly BioForm Medical) from July 2007 to January 2013. From March 2006 to May 2007, Mr. Condon was President and Chief Executive Officer of Aspara Medical and was President and Chief Executive Officer of Reliant Technology from January 2005 to February 2006. Before joining Reliant Technology, Mr. Condon held various roles at Spa Medicus, The Plastic Surgery Company and Mentor Corporation. Mr. Condon has served on the Board of Directors of Suneva Medical since September 2016 and AirXpanders Inc from 2012 to July 2019. Mr. Condon holds a bachelor’s degree in Biological Science from the University of California, Davis.

Ms. Custin has served on our Board since July 2020. She served as Chief Financial Officer and on the board of directors of Siemens Medical Solutions Inc. from February 2012 to December 2019. Ms. Custin previously served as Chief Operating and Financial Officer of Scient’x and President and CEO USA of Draeger Medical Systems from 2004 to 2008. She has served on the Board of Directors of Mayne Pharma Group since March 2022 and Volpara Health Tech since September 2021. Ms. Custin holds a B.A. in Accounting from Queens College, CUNY.

Ms. Gillin has served on our Board since December 2020. She has been the Chief Growth Officer of Pagaya Technologies LTD since October 2021, where she oversees business development, partnerships, marketing, and leads growth for the company and its partners. Previously, Ms. Gillin served as Chief Marketing Officer of JPMorgan Chase & Co. from January 2020 to April 2021 and as President, Co-Brand Cards from February 2017 to January 2020. Ms. Gillin has over 25 years of experience in senior executive leadership roles at Bank of America, Citi, and JP Morgan Chase. Ms. Gillin holds a B.A. in International Relations and Affairs from the University of Delaware.

Mr. Schutter has served on our Board since September 2015. He was Chief Executive Officer of Arbor Pharmaceuticals from 2010 to 2021. Before Arbor, Mr. Schutter served as President of Sciele (Shionogi U.S.) Pharmaceuticals. Prior to that, he served as Vice President of Global Business Development at Solvay Pharmaceuticals based in Basel, Switzerland. He has also held several senior management roles at the U.S. subsidiary of Solvay during his twenty years with the organization. He began his pharmaceutical career with Reid-Provident Labs, a small entrepreneurial pharmaceutical company based in Atlanta, GA. Mr. Schutter is a registered pharmacist with a BS degree in Pharmaceutical Sciences from Mercer University, an MBA from Kennesaw State University, and has completed graduate studies in International Business at Njienrode University, Amsterdam, Netherlands. He is currently a board member of Terrascend (TER.CN:CNQ), Vitruvias Therapeutics, and Intrance Medical and has been a previous board member of several other public, private and non-profit organizations.

Chair of the Compensation Committee
Member of the Audit Committee

Mr. Slotkin has served on our Board since July 2020. He has been a partner with PJT Partners, a global advisory-focused investment bank, since June 2018. Mr. Slotkin was a partner of Discovery Land Company from July 2017 to June 2018, and a Managing Director of Goldman Sachs from May 2007 to June 2017. Mr. Slotkin holds a B.S. in Finance from Rutgers College, and a J.D. and M.B.A. from George Washington University.